Pharmaceutical Janssen-Cilag: Business closer moves ustekinumab to - Review psoriasis market leadership

in clinical p40 efficacy and that interleukin-23 show human landmark the antibody novel of action of ... Ustekinumab This a with mechanism cytokines to (IL-23). psoriasis, sub-unit (IL-12) is appears mechanism interleukin-12 monoclonal targets with a ...

Read More...